Perrigo Company plc (PRGO)
Market Cap | 3.66B |
Revenue (ttm) | 4.34B |
Net Income (ttm) | -180.20M |
Shares Out | 136.46M |
EPS (ttm) | -1.31 |
PE Ratio | n/a |
Forward PE | 8.52 |
Dividend | $1.16 (4.33%) |
Ex-Dividend Date | Mar 7, 2025 |
Volume | 2,689,862 |
Open | 26.45 |
Previous Close | 26.41 |
Day's Range | 26.39 - 27.27 |
52-Week Range | 23.14 - 33.46 |
Beta | 0.45 |
Analysts | Buy |
Price Target | 33.00 (+23.13%) |
Earnings Date | May 7, 2025 |
About PRGO
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain rel... [Read more]
Financial Performance
In 2024, Perrigo Company's revenue was $4.37 billion, a decrease of -6.06% compared to the previous year's $4.66 billion. Losses were -$171.80 million, 1252.8% more than in 2023.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for PRGO stock is "Buy." The 12-month stock price forecast is $33.0, which is an increase of 23.13% from the latest price.
News

Perrigo Company plc (PRGO) Q1 2025 Earnings Call Transcript
Perrigo Company plc (NYSE:PRGO) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations Patrick Lockwood-Taylor - Pre...

Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations
Advancing 'Three-S' Plan to Stabilize, Streamline and Strengthen Perrigo, which was Detailed at February 2025 Investor Day Delivered Strong First Quarter 2025 Adjusted EPS Growth and Margin Expansion,...

Perrigo Announces Quarterly Dividend
DUBLIN , April 30, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly div...

Perrigo: Opill Shows Where The Company Wants To Be
Perrigo's transformation from a low-margin generics manufacturer to a branded consumer self-care company hinges on the success of products like Opill and Mederma. Despite short-term revenue declines, ...

Perrigo to Release First Quarter 2025 Financial Results on May 7, 2025
DUBLIN , April 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2025 financial res...

Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan
J.P. Morgan say s Perrigo Company plc's PRGO first-quarter 2025 earnings will be dominated by commentary on the potential impact of tariffs. The analyst says, “Tariffs could potentially have a signif...

Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S. manufacturin...

Perrigo Company plc (PRGO) 2025 Investor Day (Transcript)
Perrigo Company plc (NYSE:PRGO) Perrigo 2025 Investor Day February 28, 2025 8:00 AM ET Company Participants Brad Joseph - Vice President, Investor Relations Patrick Lockwood-Taylor - President and Ch...

Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual Investor Day
DUBLIN, Feb. 28, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that at its Virtual Investor Day, scheduled to begin today at...

31 Upcoming Dividend Increases, Including 3 Kings
This week sees 31 dividend increases, including three Dividend Kings: Genuine Parts, Commerce Bancshares, and Kimberly-Clark, showcasing impressive financial stability and growth. My investment strate...

Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations
Making Significant Progress on Stabilizing, Streamlining and Strengthening Organization to Build Long-Term Sustainable, Value Accretive Growth Delivered Fiscal Year 2024 Adjusted EPS of $2.57 the Mid-...

Perrigo to Attend the UBS 2025 Global Consumer and Retail Conference
DUBLIN , Feb. 26, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduar...

Perrigo Increases Quarterly Dividend by 5%
DUBLIN , Feb. 19, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors has approved a 5% increas...

Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and expansion of partnerships
--WNBA and Opill® continue partnership with Level The Court initiative-- GRAND RAPIDS, Mich. , Feb. 4, 2025 /PRNewswire/ -- Today, Opill®— the first and only daily birth control pill available without...

Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual Investor Day on February 28, 2025
DUBLIN, Ireland , Jan. 31, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its fourth quarter and fisca...

Perrigo Paves The Way For Recovery With Margin Focus
Perrigo is a focused OTC consumer healthcare player, slimming down operations and enhancing margins under new management, with a 4.6% dividend yield. Despite short-term pressures from a weak cold-and-...

Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer
Expanded Scientific Office Unifies Scientific-Focused Teams, Facilitating Seamless Collaboration Across Product Portfolio Lennox Most Recently Led Regulatory, Medical Affairs, Safety and Quality Teams...

Perrigo Company: Great Combination Of Future Growth With A Low Valuation
Perrigo's long-term growth is driven by strategic initiatives like Project Energize, aiming for $140-$170 million in annualized savings by 2026. The company's reinvestments in leadership and IT, addin...

Perrigo Company plc (PRGO) Q3 2024 Earnings Call Transcript
Perrigo Company plc (NYSE:PRGO) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations Patrick Lockwood-Taylor ...

Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations
Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perri...

Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024
DUBLIN , Oct. 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2024 financial resu...

WNBA Star Napheesa Collier Joins Team Opill® for Candid Conversations on Women's Health
Opill® and Collier will hit the road to talk to women about their reproductive health options. GRAND RAPIDS, Mich.

Perrigo Announces Good Start® and Dr. Browns® Brand Partnership and Launch of Infant Formula Portfolio
DUBLIN , Sept. 26, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced a new brand partnership: Good Start®1 and Dr. Brown'...

PERRIGO ANNOUNCES THE CLOSING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY
DUBLIN , Sept. 17, 2024 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) today announced the closing of a registered public offering by Perrigo Finance Unlimited Company, ...

PERRIGO ANNOUNCES THE PRICING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY
DUBLIN , Sept. 12, 2024 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) today announced the pricing of a registered public offering by Perrigo Finance Unlimited Company, ...